1. Home
  2. RCMT vs MSLE Comparison

RCMT vs MSLE Comparison

Compare RCMT & MSLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RCM Technologies Inc.

RCMT

RCM Technologies Inc.

HOLD

Current Price

$19.36

Market Cap

140.8M

ML Signal

HOLD

MSLE

Satellos Bioscience Inc. Common Stock

N/A

Current Price

$5.74

Market Cap

146.9M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
RCMT
MSLE
Founded
1971
N/A
Country
United States
Canada
Employees
N/A
17
Industry
Professional Services
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
140.8M
146.9M
IPO Year
1997
N/A

Fundamental Metrics

Financial Performance
Metric
RCMT
MSLE
Price
$19.36
$5.74
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
41.2K
107.8K
Earning Date
05-06-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.34
N/A
Revenue
$186,737,000.00
N/A
Revenue This Year
$16.29
N/A
Revenue Next Year
$6.92
N/A
P/E Ratio
$14.43
N/A
Revenue Growth
5.83
N/A
52 Week Low
$14.88
$5.75
52 Week High
$28.19
$13.39

Technical Indicators

Market Signals
Indicator
RCMT
MSLE
Relative Strength Index (RSI) 53.14 23.26
Support Level $19.35 N/A
Resistance Level $20.91 $7.94
Average True Range (ATR) 0.96 0.86
MACD 0.04 -0.21
Stochastic Oscillator 65.69 0.24

Price Performance

Historical Comparison
RCMT
MSLE

About RCMT RCM Technologies Inc.

RCM Technologies Inc is a provider of business and technology solutions designed to enhance and maximize the operational performance of its customers. It operates in three segments: Specialty Health Care, Engineering, and Life Sciences, Data and Solutions (LS&D). The company generates maximum revenue from the Specialty Health Care segment that provides staffing solutions including medical healthcare professionals, health information management professionals, nurses, paraprofessionals, physicians, and therapists. Geographically, it derives a majority of its revenue from the United States and also has a presence in Canada, Puerto Rico, the Philippines, and Europe.

About MSLE Satellos Bioscience Inc. Common Stock

Satellos Bioscience Inc is a regenerative medicine company a biotechnology and drug development company. The company is developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. The company's program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation which Satellos has identified as a root cause of the progressive nature of this disease.

Share on Social Networks: